Concepedia

Benika J. Pinch

BJ

8

Publications

839

Citations

8

H-Index

2016

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Beth Israel Deaconess Medical Center

Cancer Research Institute

Translational Therapeutics (United States)

Benika J. Pinch is an author at Dana-Farber Cancer Institute specializing in medicine, cell biology, and pharmacology.

Top concepts

MedicineCell BiologyPharmacologyTumor BiologyCancer BiologyCellular BiochemistryOncologyCell CycleImmunologyBiochemistry

Publications per year

2016–2024

8

Publications

8

Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapy

Kazuhiro Koikawa, Shin Kibe, Futoshi Suizu et al. · Cell · 2021 · 231 citations · Full text

Pancreatic Cancer, Gastrointestinal Oncology, Medicine +4

Arsenic targets Pin1 and cooperates with retinoic acid to inhibit cancer-driving pathways and tumor-initiating cells

Shingo Kozono, Yu‐Min Lin, Hyuk‐Soo Seo et al. · Nature Communications · 2018 · 159 citations · Full text

Sulfopin is a covalent inhibitor of Pin1 that blocks Myc-driven tumors in vivo

Christian Dubiella, Benika J. Pinch, Kazuhiro Koikawa et al. · Nature Chemical Biology · 2021 · 141 citations · Full text

Covalent Inhibitor, Oncology, Malignant Disease +9

Development and Characterization of a Wee1 Kinase Degrader

Zhengnian Li, Benika J. Pinch, Katherine A. Donovan et al. · Cell chemical biology · 2019 · 99 citations · Full text

Cell Division, Receptor Tyrosine Kinase, Protein Degradation +6

Identification of a potent and selective covalent Pin1 inhibitor

Benika J. Pinch, Zainab M. Doctor, Behnam Nabet et al. · Nature Chemical Biology · 2020 · 83 citations · Full text

Molecular Docking, Medicinal Chemistry, Drug Target +4

Rows per page

1–5 of 8